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Basic helix-loop-helix transcription factors Olig1 and Olig2 critically regulate oligodendrocyte
development. Initially identified as a downstream effector of Olig1, an oligodendrocyte-specific zinc finger
transcription repressor, Zfp488, cooperates with Olig2 function. Although Zfp488 is required for
oligodendrocyte precursor formation and differentiation during embryonic development, its role in
oligodendrogenesis of adult neural progenitor cells is not known. In this study, we tested whether Zfp488
could promote an oligodendrogenic fate in adult subventricular zone (SVZ) neural stem/progenitor cells
(NSPCs). Using a cuprizone-induced demyelination model in mice, we examined the effect of
retrovirus-mediated Zfp488 overexpression in SVZ NSPCs. Our results showed that Zfp488 efficiently
promoted the differentiation of the SVZ NSPCs into mature oligodendrocytes in vivo. After
cuprizone-induced demyelination injury, Zfp488-transduced mice also showed significant restoration of
motor function to levels comparable to control mice. Together, these findings identify a previously
unreported role for Zfp488 in adult oligodendrogenesis and functional remyelination after injury.
D
emyelination in the central nervous system (CNS) is associated with a wide variety of disorders that either
directly or indirectly induce oligodendrocyte (OL) injury or loss1. Although remyelination and recovery
could occur under certain conditions 2, they are often limited and incomplete in acute injury or disease.
Chronic demyelination of the CNS results in axonal degeneration and permanent loss of function 3. AlthoughOL
progenitors (OPs) are widely distributed in the adult CNS 4, 5 and are often not directly affected by demyelination
lesions 6, 7, several studies point out that the prevailing pathological milieu in demyelination lesions can prevent
OP proliferation 8, 9 and their differentiation into mature OLs 10, 11. Emerging studies indicate that neural stem/
progenitor cells (NSPCs) in the neurogenic zones of the adult brain, including the subventricular zone (SVZ) and
the hippocampal subgranular zone, can give rise to OPs and differentiate into OLs in conditions of myelin loss 12–14.
However, the potential contribution of adult NSPCs to OL regeneration and remyelination still remains largely
unclear.
Several stage-specific transcription factors have been identified to be responsible for coordinating OL differ-
entiation 15–17. The basic helix-loop-helix (bHLH) transcription factors Olig1 and Olig2 have been demonstrated
to play key roles in regulating OL development. Olig2 expression leads to the expression of other downstream
factors, such as the homeobox factor Nkx2.218, and another bHLH protein Mash1 19 that promote differentiation
to the early OL lineage. Olig2 also induces expression of the HMG-box transcription factor Sox10 that cooperates
with Olig1 and is required for terminal OL differentiation 20, 21. Other transcription factors such as Sox 9 are
required for switching from a neuronal to a glial lineage 22. Sox 9 and Sox 10 in turn regulate the expression of
platelet derived growth factor receptor a (PDGFRa) in OPs 23, while Nkx2.2 influences Sox10 and Olig2 express-
ion 18.Moreover, a decrease in expression of transcriptional inhibitors, such asHes5, Id2 and Id4, increasesmyelin
gene expression and promotes terminal OL differentiation 24–26. Although not clearly demarcated in the literature,
it has been suggested that Olig2 is the major transcription factor in OL lineage specification during development
and that Olig1 may be important for remyelination and repair after demyelination lesions 27.
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Further studies into the oligodendrogenic transcription network
led to the identification of several OL-specific zinc finger proteins
(Zfps) required for OL differentiation. Among these, Zfp191 is
required for the myelinating function of OLs 28, Zfp Yin Yang 1
(YY1) regulates OP differentiation into mature OLs 29, and Zfp488
regulates OP formation and differentiation during embryonic
development 30. Zfp488 was initially identified in a screen for differ-
entially expressed genes in OLs from Olig1 knockout mice.
Biochemical analysis revealed that it physically interacts with
Olig2. In the chick neural tube, ectopic expression of Zfp488 induced
precocious OL differentiation. Under conditions of constitutive
Notch activation, Zfp488 expression also promotes precocious OP
formation 30. In vivo characterization of Zfp488 inmice and its role in
remyelination and repair remain to be studied.
In this manuscript, we examined whether Zfp488 induces oligo-
dendrogenesis of SVZ NSPCs in the adult mouse brain after cupri-
zone-mediated myelin injury. We show that induced expression of
Zfp488 in SVZ NSPCs significantly improved the number of OLs in
the corpus callosum and translated to functional recovery. These
observations clearly indicate that Zfp488 can promote oligodendro-
genesis of SVZNSPCs in the adult mouse brain. This new knowledge
on Zfp488 has important implications in CNS myelin regeneration
and repair after demyelinating diseases.
Results
Experimental design. Zfp488 expression was under the control of a
Moloney murine leukemia virus-long terminal repeat (MoMuLV-
LTR; Figure 1A). Expression of Zfp488 was confirmed after a trial
retroviral infection in 293T cells using both ZsGreen1 reporter
fluorescence (Figure 1B) and western blots (Figure 1C). A well-
characterized repressor element present in stem cells prevents
expression of MoMuLV-LTR prior to their differentiation 31. By
infecting mouse ES cells, we confirmed that there was no
expression of Zsgreen1 and also found that expression was not
observed even in embryoid bodies. This unique property allowed
for the controlled or timed ‘‘switch on’’ of Zfp488 expression as
progenitor cells start to differentiate but not during self-renewal
within the SVZ NSPCs. In vivo, after delivery to the SVZ, the
distribution of the ZsGreen1 positive cells was initially contained
to the region immediately adjoining the ventricle on the ipsilateral
side only (Figure 1D), consistent with in vitro observations. More-
over, the property of retroviruses to only integrate in proliferating
cells allowed the specific targeting of proliferating SVZ progenitors at
the specific injection locus. During the 5 weeks on a 0.2% cuprizone
diet, mice progressively lost myelin, indicated by the loss of myelin
basic protein (MBP) staining in the corpus callosum (Figure 1E).
Mice on a cuprizone diet for 2 weeks underwent the procedure for
intracerebral injection of Zfp488-expressing or control retroviruses
into the SVZ. These mice continued on cuprizone diet for additional
3 weeks to reach the peak of demyelination and then removed from
the cuprizone diet. Periodic analyses of histopathology and behavior
were performed during the recovery phase. Recovery was examined
for 6 additional weeks (Figure 1F).
Zfp488 promotes differentiation of SVZ progenitor cells to OLs.
In order to examine whether forced expression of Zfp488 in
differentiating SVZ NSPCs would direct an oligodendrogenic fate
after cuprizone-induced demyelination, we examined mice that
underwent an intracerebral injection of retroviral Zfp488-
ZsGreen1 in the SVZ in comparison to control ZsGreen1 injected
mice. At the peak of demyelination (5 weeks) we examined
histological sections of the brain for the co-localization of
ZsGreen1 (retrovirus infected differentiated cells derived from SVZ
progenitor cells) and Olig2. In Zfp488 retrovirus injected mice,
ZsGreen1 expressing cells were abundant within the corpus
callosum and co-labeled with Olig2 at a significantly higher rate
Figure 1 | Experimental design and retroviral vector construction. (a)
Schematic showing retroviral constructs, both empty vector (control) and
with an insert coding for mouse Zfp488. After transduction, a Moloney
murine leukemia virus (MMLV) long terminal repeats (LTR) drives Zfp488
expression. The vectors also express the fluorescent protein ZsGreen1 after an
IRES to enable their identification and tracking. This promoter is not active in
progenitor cells due to expression of a specific repressor element, but is
transcribed once these cells start to differentiate. (b) ZsGreen1 fluorescence in
Zfp488-overexpressingHEK293T cells. (c)Western blots ofZfp488 retrovirus
transduced HEK 293T lysate showing increased expression of Zfp488. (d)
Representative Olig2 (red) immunolabeled image of the white matter
adjoining the SVZ, 3 weeks after retrovirus injection, showing the distribution
and integration of ZsGreen positive cells in mice that were not treated with
cuprizone. (e) Images showing demyelination of the corpus callosum at
different time points after cuprizone treatment. Sections were stained for
myelin basic protein (MBP, red) andDAPI (blue). (f) For all experiments, two
groups of mice were fed a 0.2% cuprizone diet for a period of 5 weeks. At two
weeks, intracerebral injections into the SVZ of either control or Zfp488
expressing-retroviruses were carried out using a stereotaxic frame. After 5
weeks, mice in group I were used for behavior analysis and
immunohistochemical characterization. Mice in group II were allowed to
recover for an additional 6 weeks on normal diet without cuprizone. After the
6-week recovery period, tissues were collected to examine for the long-term
survival of the retrovirus transduced-differentiated cells. Scale bar, 100 mm.
www.nature.com/scientificreports
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(68 6 8.6 %; p50.003; Figure 2A and 2C) compared to the control
retrovirus injected mice (25 6 5 %; Figure 2B and 2C). Zfp488
expressing cells were observed to have migrated the entire length
of the corpus callosum with the number of positive cells
progressively reducing as the corpus callosum tapered. We found
that in cuprizone induced demyelination, SVZ cells did not adhere
to the rostral migratory stream, and in both groups, we observed only
rare ZsGreen1 positive cells within regions of the olfactory bulb (data
not shown). A striking observation was that Zfp488-ZsGreen1
expressing cells were always exclusively restricted to the white
matter of the corpus callosum and were almost never found in
other regions of the brain. In stark contrast, control cells were
more randomly distributed in regions of both the white and grey
matter and had predominantly integrated into the neuronal circuitry
adjoining the corpus callosum white matter (labeled with HuC/HuD
in figure 4).
In addition to Olig2, Zfp488-ZsGreen1 expressing cells also co-
labeled with another OL lineage marker SOX10 and the mature OL
marker GST-p while the significantly fewer control cells observed in
the corpus callosum did not show such co-localization (Figure 2D
and E).
Zfp488-expressing OLs survive long term in the remyelinated
corpus callosum. In order to examine whether the Zfp488-infected
OLs thatmigrated to the corpus callosum from the SVZ at the peak of
demyelination were able to integrate and survive in the white matter,
we examined mice, 6 weeks after removal from the cuprizone diet.
We observed that Zfp488-ZsGreen1 expressing cells were still
abundant in the corpus callosum. These Zfp488-ZsGreen1
expressing cells co-labeled for the oligodendrocyte lineage marker
Olig2 at a significantly higher rate (60 6 3.5 %; p,0.001; Figure 3A
and 3C) compared to control-ZsGreen1 expressing cells (156 2.3 %;
Figure 3B and 3C). The cell numbers seen after 6 weeks of recovery
were similar to that observed at the peak of demyelination suggesting
that most if not all cells were able to survive long-term after
remyelination and recovery in these mice. In addition, similar to
that observed at the peak of demyelination, Zfp488-Zsgreen1
expressing cells expressed SOX10 and GST-p while the few control
cells that remained in the corpus callosum did not show any co-
localization (Figure 3D and E).
Zfp488-induceddifferentiation is predominantly oligodendrogenic.
AsSVZNSPCs are capable of differentiation into all the threemajor cell
types in the brain, neurons, oligodendrocytes and astrocytes 32, 33, we
examined the lineage commitment of Zfp488-ZsGreen1 expressing
SVZ cells compared to control cells. Using specific markers for
neurons (HuC/HuD) and astrocytes (S100b), we examined for co-
localization of Zfp488-ZsGreen1 and control cells with these
Figure 2 | Zfp488 directs the differentiation of SVZ progenitor cells into mature oligodendrocytes at the peak of cuprizone-induced demyelination.
Mice on a 0.2% cuprizone diet for 2 weeks were injected with either control or Zfp488 expressing retroviruses into the SVZ. After 5 weeks in the cuprizone
diet, brain sections were evaluated for the differentiation status of the virus transduced SVZ stem/progenitor cell population. (a) Representative image of
the Zfp488 virus transduced SVZ-derived cells in the whitematter of the corpus callosum.Highermagnification panel show that cells transduced with the
Zfp488 retrovirus differentiated into oligodendrocytes and were positive for Olig2. (b) Representative image of the control (ZsGreen1) virus transduced
SVZ-derived cells in the white matter of the corpus callosum. Higher magnification panel show that cells transduced with the control retrovirus did not
differentiate into oligodendrocytes andwere negative forOlig2. (c) Percentage of virus-transduced SVZ-derived cells that expressedOlig2. The number of
ZsGreen1 positive cells that were positive for Olig2 was significantly higher inmice overexpressing Zfp488 (n54) compared to controls (n55, p50.003).
(d) SVZ-derived cells in the corpus callosum at 5 weeks of cuprizone-induced demyelination. Representative images show that Zfp488-expressing cells
were also positive for the oligodendroglial marker Sox10 compared to control cells that were negative for Sox10. (e) SVZ-derived cells in the corpus
callosum at 5 weeks of cuprizone-induced demyelination. Representative images show that Zfp488-expressing cells were also positive for the mature
oligodendrocyte marker GSTp compared to control cells that were negative for GSTp. Scale bars, 100 mm and 50 mm for the lower and higher
magnification images, respectively.
www.nature.com/scientificreports
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markers. We observed that Zfp488-ZsGreen1 expressing cells were
mostly confined to the corpus callosum and rarely co-expressed
markers for neurons or astrocytes at either the peak of demyelination
(Figure 4A and B) or after the 6-week recovery period (Figure 4C and
D) suggesting that their differentiation was predominantly oligoden-
drogenic. In contrast, control cells thatweremore randomly distributed
in the brain extensively co-labeled with markers for neurons and
astrocytes at both the peak of demyelination and 6 weeks of recovery
(Figure 4) suggesting that their lineage was randomized during the
recovery phase. These observations along with the distribution
patterns of SVZ-derived cells in the brain provides additional
evidence that Zfp488 expression in SVZ cells targets them to the
white matter of the corpus callosum and are destined to an OL fate.
Zfp488-induced remyelination results in improved functional
recovery. Next, we examined whether enhanced oligodendrogenesis
contributed by directing the differentiation of adult SVZNSPCs with
Zfp488 could be measured by functional recovery parameters. In
order to test functional end points, we assessed the performance of
Zfp488 injected and control groups of mice on an accelerating
rotarod test and subsequently a grip strength test. We performed
these tests during the early recovery period immediately after they
were removed from a cuprizone diet after 5 weeks for 3 days.We also
assessed an age matched sham group of mice that did not receive the
cuprizone diet. Initial results from these trials were consistent with
the literature in that cuprizone-treated mice performed poorly in
these motor tests compared to sham 34 (Figure 5). Evaluating
functional recovery in comparison to the sham group, we found
that at Day 3, Zfp488 recovered to a level that it was no longer
different from the sham (p50.84); whereas, performance of the
cuprizone control group remained significantly lower (p50.02).
Within treatment groups, we also recorded that the Zfp488 group
had significantly improved abilities of motor control on the
accelerating rotarod that was statistically significant compared to
control group (p50.02). This finding suggested that a significant
improvement in motor function occurred in the Zfp488 group.
This result was strengthened by the more stringent analysis that
mean total run time calculated for the entire 3 days was also
significantly higher for the Zfp488 group compared to control
group (p50.03; n520/group; Figure 5A).
For a measure of peripheral neuromuscular function, we exam-
ined both forelimb and hindlimb grip strength as a response not
directly associated with CNS remyelination and recovery. In all three
trials (Days 1–3), the performance of both Zfp488 and control groups
Figure 3 | Mature oligodendrocytes derived fromZfp488 overexpressing SVZprogenitor cells survive after complete recovery from cuprizone-induced
demyelination. Mice on a 0.2% cuprizone diet for 2 weeks were injected with either control or Zfp488 expressing retrovirus into the SVZ. After cuprizone
treatment for 5 weeks, mice were allowed to recover and remyelinate for 6 weeks on normal chow. After 5 weeks in the cuprizone diet, brain sections were
evaluated for the differentiation status of the virus-transduced SVZ progenitor cell population. (a) Representative image of the Zfp488 virus transduced
SVZ-derived cells in the white matter of the corpus callosum. Higher magnification panel show that cells transduced with the Zfp488 retrovirus
differentiated into oligodendrocytes and were positive for Olig2. (b) Representative image of the control (ZsGreen1) virus transduced cells in the white
matter of the corpus callosum. Higher magnification panel show that cells transduced with the control retrovirus did not differentiate into
oligodendrocytes and were negative for Olig2. (c) Percentage of virus-transduced SVZ-derived cells that express Olig2. The number of ZsGreen1 positive
cells that were positive forOlig2was significantly higher inmice expressing Zfp488 (n55) compared to controls (n54, p,0.001). (d) SVZ-derived cells in
the corpus callosum after 5 weeks of cuprizone-induced demyelination followed by 6 weeks of recovery. Representative images showed that Zfp488
expressing cells were also positive for the oligodendroglial marker Sox10 compared to control cells that were negative for Sox10. (e) SVZ-derived cells in
the corpus callosum after 5 weeks of cuprizone-induced demyelination followed by 6 weeks of recovery. Representative images showed that Zfp488-
expressing cells were also positive for themature oligodendrocytemarker GSTp compared to control cells that were negative for GSTp. Scale bars, 100 mm
and 50 mm for the lower and higher magnification images, respectively.
www.nature.com/scientificreports
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that received cuprizone was at a level lower than the sham group. As
expected, we did not detect any significant improvements in Zfp488
group compared to control group in both forelimb and hindlimb grip
strength tests (n519–20; Figure 5B and C). These data suggest that
the recovery observed in the rotarod performance is associated with
enhanced remyelination in the corpus callosum of the Zfp488 group
of mice.
Discussion
Zfp488 was recently reported as a highly conserved OL-specific tran-
scription factor with functions potentially interwoven with other
factors critical for oligodendrogenesis 30. In this study, we examined
the specific function of Zfp488 in OL development and differenti-
ation in vivo after timed overexpression in SVZ NSPCs. By using a
cuprizone-induced demyelination mouse model, we demonstrate
that Zfp488 could significantly promote an oligodendrogenic fate
of differentiating SVZ NSPCs and enhance functional recovery.
SVZ NSPCs have been used as a tool to scrutinize factors that
promote oligodendrocyte fate specification and remyelination in
vivo in several studies 35–37. The SVZ is a major source of NSPCs in
the adult mouse brain. These NSPCs correspond to a population of
astrocyte-like cells (type B cells) that give rise to actively proliferating
transit amplifying type C cells 38. Under physiological conditions,
SVZ type C cells contribute to formation of neuroblasts (type A cells)
that migrate via the rostral migratory stream (RMS) to the olfactory
bulb and replace interneurons 39. Under demyelinating CNS pathol-
ogies, SVZ NSPCs have been shown to be able to proliferate and
generate both parenchymal OPs and mature OLs, most of which
are found integrated in the corpus callosum 12–14, 40.
Several studies have examined the different cues required to direct
SVZ NSPC differentiation into OPs and subsequently to OLs 41, 42. In
a lysolecithin-induced demyelination model, intraventricular infu-
sion of epidermal growth factor dramatically promoted proliferation,
migration and differentiation of SVZ NSPCs into OLs 43. In another
study adenoviral expression of leukemia inhibitory factor signifi-
cantly promoted SVZ NSPC self-renewal 44. Similarly, intraventricu-
lar infusion of the BMP inhibitor Noggin also increased the number
of Olig2-positive OLs in mice after cuprizone-induced demyelina-
tion 35. In addition to the use of diffusible factors, several experiments
have explored intrinsic transcriptional fate determinants that regu-
late OL development and differentiation from SVZ NSPCs 45.
Inducible overexpression of Olig2 and Olig1 have been identified
to play crucial roles in determining an OL fate during SVZ NSPC
differentiation in vivo 46.
In this study, we examined the oligodendrogenic effect of timed
Zfp488 overexpression in differentiating SVZNSPCs in a cuprizone-
induced demyelination model. The MMLV LTR element driving
Zfp488 expression was not constitutively active in SVZ NSPCs but
was restricted to only differentiating cells migrating out of this
region. In addition, the use of a chemical-induced demyelination
model in mice had unique experimental advantages in that the
SVZ is in close proximity to the corpus callosum and cuprizone
treatment can be terminated to allow a more direct analysis of dif-
ferent cellular contributions to remyelination. In cuprizone treat-
ment, myelin loss has been shown to be specifically associated with
the loss of mature OLs but not their progenitors 47–49. Moreover,
treating with cuprizone does not have any effect on the peripheral
nerves 50. Unlike the autoimmune demyelination pathology seen in
multiple sclerosis or experimental autoimmune encephalomyelitis,
cuprizone-induced demyelination lacks secondary complications
brought about by blood brain barrier breakdown and therefore does
not adversely affect the CNS microenvironment allowing for near
complete remyelination. This feature makes it ideal to examine OL
precursor formation and differentiation from SVZ NSCs in the
absence of secondary pathological effects 27. The absence of immune
cells in this model also supports increased proliferation of OPs 27.
Moreover, functional correlates for longitudinal analysis allow for
the evaluation and comparison of demyelination and remyelination
in detail under different experimental conditions 51.
OL differentiation after demyelination is dependent on both
extrinsic and intrinsic factors 3. Different factors that promote OL
differentiation of NSPCs have been identified to be upregulated
in and around the SVZ. For example: p75(NTR), the low-affinity
neurotrophin receptor, has been shown to be upregulated by
Figure 4 | Zfp488 overexpressing SVZ cells did not differentiate into
neurons or astrocytes. Mice on a 0.2% cuprizone diet for 2 weeks were
injected with either control or Zfp488 expressing retrovirus into the SVZ.
After 5 weeks in the cuprizone diet and 6 weeks recovery on normal chow,
brain sections were evaluated for the SVZ cells that had differentiated into
neuronal and astrocytic populations. (a) At 5 weeks, a population of
control virus expressing SVZ-derived cells in the corpus callosum co-
localized with the neuronal marker HuC/HuD (arrows); however, Zfp488
overexpressing cells did not differentiate into neurons and were negative
for HuC/HuD. (b) At the same 5 week time point, a population of control
virus expressing SVZ-derived cells in the corpus callosum co-localizedwith
the astrocyte marker S100b (arrows); however, Zfp488 over expressing
cells did not differentiate into mature astrocytes and were negative for
S100b. (c) After 6 weeks of recovery from cuprizone-induced
demyelination, both control and Zfp488 overexpressing cells were
restricted to the white matter tract and were negative for the neuronal
marker HuC/HuD. (d) At the same 6 weeks of recovery, most control virus
expressing cells co-localized with the astrocyte marker S100b (arrows);
however, Zfp488 overexpressing cells did not give rise to an astrocyte
population and were negative for S100b. Scale bars, 50 mm.
www.nature.com/scientificreports
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oligodendroglial progenitors adjacent to the subventricular zone in
response to demyelination 52. More recently, chordin, a factor that
could redirect GAD65 and doublecortin positive NSPCs to an glial
rather than neuronal lineage has also been reported to be responsible
for generating newOLs in the corpus callosum after demyelination 12.
In this study, mice were injected with a Zfp488 retrovirus after
two weeks on a cuprizone diet when there is a high rate of OPC
proliferation at onset of demyelination 53. At the peak of demyelina-
tion, we located the Zfp488-ZsGreen1 expressing OLs that were
confined to the corpus callosum white matter tract. We observed
that Zfp488 over expressing SVZ NSPCs differentiated readily into
OLs compared to controls. At the end of the recovery period, Zfp488
overexpressing OLs had migrated along the entire corpus callosum,
showing integration and survival in the newly generated white matter.
Figure 5 | In vivo overexpression of Zfp488 in SVZ progenitor cells improved functional recovery in mice after cuprizone-induced demyelination. (a)
Cuprizone-treated mice induced to overexpress Zfp488 in SVZ cells (Zfp-cz, n520) were examined for motor function and compared to control virus
injectedmice (Con-cz, n520) and shammice on normal chow (Sham, n519). Themice induced to over express Zfp488 in SVZ stem cells (Zfp-cz) stayed
significantly longer on the rod compared to control (Con-cz) mice on Day 3. This difference was also apparent on the mean run time for all 3 days.
In addition, day 3 of testing andmean run time shows that themotor control of the Zfp488 overexpressing cells matched that of the shammice (* p50.05
vs Sham, *** p50.01 vs Sham, ^^ p50.02 vs Con-cz, ^ p50.03 vs Con-cz). (b) Forelimb grip test on both groups of cuprizone-treated mice (Zfp-cz and
Con-cz) showed significantly lower scores compared to the group of sham mice. However, there were no statistically significant differences between the
Zfp-cz and the Con-cz group (** p50.02 vs Sham) (c) Hindlimb grip test on both groups of cuprizone-treated mice (Zfp-cz and Con-cz) showed
significantly lower scores compared with the group of sham mice. However, there were no statistically significant differences between the Con-cz and
Zfp-cz groups (*** p50.01 vs Sham).
www.nature.com/scientificreports
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It is possible that Zfp488 overexpression might lead to increased
proliferation of the progenitors targeted by the retrovirus or cause
cell death of other neuronal lineages. However previous in vitro
studies definitively indicated that Zfp488 overexpression directs dif-
ferentiation of progenitors to oligodendrocyte precursors 30. We also
observed an identical number ZsGreen1 expressing cells in the cor-
pus callosum white matter and adjoining grey matter in both Zfp488
transduced and control virus transduced cells respectively, further
confirming that there was neither cell death nor proliferative effects
as a result of Zfp488 expression. Although these cells labeled for
different markers the transduction efficiency was similar in both
conditions. The deficiency of ZsGreen1 positive cell migration into
the olfactory bulb through the rostral migratory stream could be
explained by the extreme demyelinating milieu 54, and poor oligo-
dendrogenesis in the olfactory bulb 55, of this cuprizone demyelina-
tion mouse model. In addition, Zfp488 transduced Olig2 positive
cells were always localized to the white matter tract at both the peak
of demyelination and 6 weeks after recovery (i.e. 11 weeks after
starting the cuprizone diet) suggesting that the differentiation fate
of these cells remained oligodendroglial rather than astrocytic. In
contrast the control virus transduced cells differentiated into astro-
cytes (S100b positive) and neurons (HuC/HuD positive) as expected
of the multipotent progenitors targeted by the virus. The absence of
S100b staining on the Zfp488 transduced cells and their strict white
matter localization is further confirmation that these cells do not
differentiate to astrocytes.
These histochemical findings were in strong correlation with
improvement in motor function observed in the Zfp488 injected
mice. Cuprizone-induced demyelination is known to impair corpus
callosum-associated bilateral sensorimotor coordination in mice 34, 51.
After 5 weeks on a cuprizone diet (peak of demyelination), deficits
were evident in the frequency of falls and the running time on the
rotarod, consistent with corpus callosum demyelination. Our obser-
vations clearly showed that the Zfp488 group performed significantly
better in run times compared to controls. Remarkably at day 3, the
performance of the Zfp488 group was similar to sham group that did
not receive a cuprizone diet suggesting a significant recovery in this
group. In order to explore the specificity of the corpus callosum
demyelination and this recovery effect, we also analyzed forelimb
and hindlimb grip strength, indicators of peripheral neuromuscular
function 56. We did not find any differences between the Zfp488
group and control group in this functional test demonstrating that
the increased motor coordination observed in the Zfp488 group was
indeed due to specific CNS effects that involve remyelination in the
corpus callosum. Although astrocytes and neurons have been
reported to influence myelination 57–59 the oligodendrogenic effect
of Zfp488 and the subsequent increase in myelination superseded
any endogenous factors as evidenced by the absence of functional
gain in the control virus injected mice.
Together, the immunohistochemical and functional data clearly
support the conclusion that Zfp488 overexpression in differentiating
NSPCs directs them to an OL fate. Attempts to localize Zfp488 pro-
tein expression during CNS OP and OL development in mice were
futile as none of the commercially available antibodies could faith-
fully identify Zfp488 in tissue sections. This issue has also been
encountered in a previous study characterizing Zfp488 inwhich, only
in situ hybridization for Zfp488 mRNA localization could be
reported 30. Nevertheless, in the present study, ZsGreen1 reporter
fluorescence reliably reflected the expression of Zfp488 protein.
Previous co-immunoprecipitation studies using recombinant
Zfp488 and Olig2 showed a physical interaction between these two
proteins in vitro 30, suggesting the involvement of Zfp488 in the
transcriptional network of Olig2 that is critical for OP and OL dif-
ferentiation 45, 46, 60. Moreover, Zfp488 expression was dramatically
reduced in Olig1 knockout mice and was shown to be regulated by
Olig1 30. Observations in this manuscript are consistent with these
reports in that a functional integration of Zfp488 with Olig1 and
Olig2 could bring about directed differentiation of SVZ NSPCs to
OLs.
Specific mechanisms that regulate OL development and differenti-
ation are not completely understood and continue to remain a topic
of active investigation. Advancing current knowledge, our results
clearly demonstrate a role for Zfp488 in oligodendrogenesis. These
results not only provide insights into the transcriptional regulation of
OL development but also identify a candidate gene to promote oli-
godendrogenesis from SVZ NSPCs in vivo after demyelination.
Methods
Reagents and animals. All chemicals and reagents were purchased from Sigma-
Aldrich (St Louis, MO), unless otherwise specified. Primary antibodies against myelin
basic protein (MBP) was from Novus Biologicals (Littleton, CO), Olig2 was from
R&D systems (Minneapolis, MN), S100b was from Sigma-Aldrich, GST-p was from
BD biosciences (San Jose, CA), HuC/HuD was from Invitrogen (Carlsbad, CA),
Sox10 was from Santa Cruz Biotechnology (Santa Cruz, CA), and Zfp488 was from
LifeSpan Biosciences (Seattle, WA) and Santa Cruz Biotechnology (S14 and C14;
Santa Cruz, CA). Fluorophore conjugated secondary antibodies were from
Invitrogen. All mice used in these experiments were purchased from Charles River
laboratories (Wilmington, MA). All animals were maintained in accordance with the
National Institutes of Health Guidelines for the Care and Use of Laboratory Animals,
and all experiments were performed with approved protocols from the Institutional
Animal Care and Use Committee of the University of California, Davis.
Plasmids and retrovirus production. The mouse Zfp488 cDNA was a gift from Dr
Richard Lu, University of Texas Southwestern Medical Center, Dallas, TX, USA. The
Zfp488 open reading frame was cloned into the pRetroX-IRES-ZsGreen1 vector from
Clontech laboratories (Mountain View, CA). The empty vector expressing ZsGreen1
was used as a control. Replication incompetent retroviruses were produced from
pRetroX-Zfp488-IRES-ZsGreen and pRetroX-IRES-ZsGreen1 (control) at the Gene
Transfer Vector Core, University of Iowa (Iowa City, IA). Titers for the concentrated
stocks were obtained for both the viruses and were .23108 TU/ml.
Cuprizone-induced demyelination. CNS demyelination was induced by cuprizone
in mice by following an established protocol 34. A diet containing 0.2% cuprizone (w/
w) was custom ordered from Lab Diet (Richmond, IN). Eight-week-old C57BL/6
male mice were fed either cuprizone or control pellet diets ad libitum for 5 weeks to
induce demyelination. Pellets were changed once every two days and the weights of
mice were recorded every week. After 5 weeks, mice were returned to a regular diet for
analyzing remyelination and recovery.
Stereotaxic retrovirus injection to the subventricular zone. Mice fed 0.2%
cuprizone for 2 weeks were used for all intracerebral injections. To perform the
procedure, mice were positioned on a stereotaxic device (David Kopf, Tujunga, CA)
under continuous isoflurane inhalation anesthesia. Target coordinates were
optimized with the following instrument settings: The headwas immobilized with the
mouse adapter (x axis at 37 mm, y axis at 215 mm, the dorsal ventral tilt at 15u and
the coronal angle at 0u) and ear bars. The anterior part of the SVZ was targeted with
the coordinates: 2 mm anterior to bregma, 1.5 lateral to midline and 2.5 mm below
dura mater. Two microliters of the retrovirus (23108 TU/ml) was injected using a
Nanoject II microinjector (Drummond Scientific Company, Broomall, PA) into the
SVZ of the right hemisphere. The injection pipette was left in place for 5 minutes to
prevent back flow before retraction.
Western blotting. 293T cells transduced with control or Zfp488-expressing
retroviruses were homogenized in ice-cold lysis buffer containing 50 mMTris-HCl,
150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl
sulphate, 2 mM EDTA (pH 7.4) and a proteinase inhibitor mixture. After clarifying
by centrifuging at 14,0003g at 4uC, protein concentration in the extracts was
determined by BCA protein assay kit (Pierce, Rockford, IL). Extracts containing 30 mg
total protein were denatured with SDS sample buffer and separated by 4–15% SDS-
PAGE (Bio-Rad Laboratories, Hercules, CA). Proteins were transferred onto
nitrocellulose membranes that were then incubated with blocking solution (5%
nonfat dried milk dissolved in TBST buffer containing 10 mM Tris-HCl, 150 mM
NaCl, and 0.1% Tween-20) for 1 hr at room temperature and incubated with an anti-
rabbit primary antibody against Zfp488 (15500, Lifespan Biosciences, Seattle,WA) or
an anti-mouse primary antibody against GAPDH (152000) at 4uC overnight.
Membranes were washed three times with TBST buffer and incubated with the
appropriate HRP-conjugated secondary antibodies (152000 dilution) for 1 hr
followed by washing three times. Signal detection was performed with a
chemiluminescence kit (Pierce, Rockford, IL).
Immunohistochemistry. Brains were collected after perfusing the mice with 4%
formaldehyde (w/v) (Electron Microscopy Sciences, Hatfield, PA). After 1 hour of
post-fixation, tissues were placed in 20% sucrose solution (w/v) for 2 days. The
samples were then embedded inOCT compound (Sakura Finetek, Torrance, CA) and
frozen in liquid nitrogen-cooled isopentane. Tenmicron sections were prepared from
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the frozen blocks in a cryotome and stored at 280uC. For staining, the non-specific
epitopes were first blocked and the cells were permeabilized using 10% normal goat
serum and 0.3% triton-X-100 in PBS at room temperature. Samples were
subsequently incubated with primary antibodies overnight at 4uC. Slides were then
washed with PBS and incubated with fluorophore-conjugated secondary antibodies
at 15200 dilutions for one hour at room temperature. Nuclear counterstaining was
carried out using DAPI (300nM, Invitrogen) before mounting the slides using
ProlongGold mounting medium (Invitrogen). Images were acquired in a Nikon A1
confocal microscope and analyzed. To enumerate and identify the number of virus
transduced cells, all ZsGreen1 expressing cells co-labeled with different
differentiationmarkers were counted from serial sections 100 mmapart. An average of
100 cells were counted for each animal, with n55 per treatment.
Behavioral analysis.Animals were divided into three groups (n519–20mice/group):
(1) sham surgery mice (0% cuprizone feeding regimen through out the study), (2)
ZsGreen1 control injections (0.2% cuprizone regimen), and (3) Zfp488 injections
(0.2% cuprizone regimen). All tests described below were conducted at the end of the
5-week period on cuprizone diet. A trained observer blinded to the different
treatment groups carried out all behavioral assessments.
Rota rod analysis: An accelerating Rota rod analysis was carried out on a Rotamex
instrument (Columbus instruments, Columbus, OH) for three consecutive days. The
mice underwent an initial training day (Day 1) on followed by two days (Day 2 and
Day 3) with three test sessions each. Each session lasted 360 seconds. The initial speed
of the rotating rod was set at 4 rpm and increased by 1 rpm every 10 seconds to a
maximum of 40 rpm. The time each animal stayed on the rod was recorded.
Grip strength test: Grip strength was measured by strain gauge (Grip Strength
Meter, Columbus Instruments). Fore- and hind-grip were measured separately on
three successive trials at the end of cuprizone treatment and averaged.
Statistical analysis. Data were analyzed using one-way analysis (ANOVA) using the
SPSS software (Chicago, IL). A Tukey post hoc test for the comparison of multiple
groups was used when appropriate. In all figures and text, data are represented as
mean 6 SEM. Significant effects were identified at p,0.05.
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